About Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics, Inc. is a clinical stage biotechnology company. The firm engages in the development of cancer vaccines designed to treat solid tumor cancers. It also offers a platform technology for DCVax dendritic cell-based vaccines. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.

At the moment the company generates 1M USD in revenues.

On its last earning announcement, the company reported a loss of -0.22$ per share.

The book value per share is -0.09$

Northwest Biotherapeutics, Inc. website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
1M - -56M - -57M -0.22 - - 390M -0.09 -35M - -35M